温阳复元方治疗缺血性中风恢复期的临床疗效观察

发布时间：2018-03-20 11:14

本文选题：缺血性中风恢复期　切入点：温阳复元方　出处：《广西中医药大学》2017年硕士论文　论文类型：学位论文

【摘要】：目的:探讨温阳复元方治疗缺血性中风病的理论依据,以及观察温阳复元方治疗缺血性中风恢复期的有效性及安全性,以期为中风病的治疗开拓新的思路,并为本方更好地应用于临床打下坚实基础。方法:根据国内对缺血性中风的诊断标准,将符合纳入标准的80例患者随机分为治疗组与对照组,每组40例。两组在常规治疗基础上分别给予温阳复元方和补阳还五汤治疗,治疗28天为一个疗程。观察两组患者治疗前后的神经功能缺损评分、运动功能评分、生活能力评分、中医证候评分的变化情况。结果:(1)临床疗效:治疗组37例,基本痊愈7例,显效17例,有效10例,无效3例,总有效率为91.89%;对照组36例,基本痊愈4例,显效12例,有效10例,无效10例,总有效率为72.22%。两组比较差异有统计学意义(P0.05),说明治疗组明显优于对照组。(2)NIHSS评分:温阳复元方与补阳还五汤均能改善缺血性中风恢复期患者的NIHSS积分(P0.05或P0.01),治疗前后差值比较(P0.05),治疗组优于对照组,提示温阳复元方可明显改善患者神经缺损功能,其疗效优于补阳还五汤组。(3)肢体运动功能评分(Fugl-Meyer):温阳复元方与补阳还五汤均能改善缺血性中风恢复期患者的Fugl-Meyer评分(P0.05或P0.01),治疗后比较,治疗组优于对照组(P0.05),提示温阳复元方可明显改善患者运动功能评分,其疗效优于补阳还五汤组。(4)日常生活能力评分(ADL):温阳复元方与补阳还五汤均能改善缺血性中风患者的ADL评分(P0.05或P0.01),治疗后比较,治疗组优于对照组(P0.05),提示温阳复元方可明显改善患者生活能力其疗效优于补阳还五汤组。(5)中医证候评分:温阳复元方与补阳还五汤均能改善缺血性中风患者的中医症候积分(P0.05或P0.01),治疗后比较,治疗组优于对照组(P0.05),提示温阳复元方可明显改善患者中医症候评分,其疗效优于补阳还五汤组。结论:本研究显示,温阳复元方治疗缺血性中风恢复期患者疗效确切、安全,能够改善缺血性中风恢复期患者的NIHSS、Fugl-Meyer、ADL、中医症候评分。
[Abstract]:Objective: to explore the theoretical basis of Wenyang Fuyuan recipe in the treatment of ischemic stroke, and to observe the efficacy and safety of Wenyang Fuyuan prescription in the treatment of ischemic stroke in convalescence, so as to open up new ideas for the treatment of apoplexy. Methods: according to the diagnostic criteria of ischemic stroke in China, 80 patients with ischemic stroke were randomly divided into treatment group and control group. 40 cases in each group were treated with Wenyang Fuyuan recipe and Buyang Huanwu decoction on the basis of routine treatment for 28 days. The neurological impairment score, motor function score and life ability score were observed before and after treatment. Results: in the treatment group, 37 cases were basically cured, 17 cases were markedly effective, 10 cases were effective, 3 cases were ineffective, the total effective rate was 91.89%, while 36 cases in the control group, 4 cases were basically cured, 12 cases were effective, 10 cases were effective. Ineffective 10 cases, The total effective rate was 72.22.The difference between the two groups was statistically significant (P 0.05), which indicated that the treatment group was obviously superior to the control group in the score of NIHSS: both Wenyang Fuyuan recipe and Buyang Huanwu decoction could improve the NIHSS score of patients with ischemic stroke in convalescent stage (P0.05 or P0.01), before treatment. The latter difference was compared with that of the control group, and the treatment group was superior to the control group. It is suggested that Wenyang Fuyuan decoction can obviously improve the function of nerve defect in patients. The curative effect was better than that of Buyang Huanwu decoction group. 3) limb motor function score: both Wenyang Fuyuan decoction and Buyang Huanwu decoction could improve the Fugl-Meyer score of patients with ischemic stroke in convalescence stage (P0.05 or P0.01). The treatment group was superior to the control group (P 0.05), suggesting that Wenyang Fuyuan Fang could improve the motor function score of the patients. The curative effect was better than that of Buyang Huanwu decoction group. 4) the ability of daily living (ADL): both Wenyang Fuyuan decoction and Buyang Huanwu decoction could improve the ADL score of ischemic stroke patients (P0.05 or P0.01). The treatment group is superior to the control group (P 0.05), indicating that Wenyang Fuyuan decoction can obviously improve the patients' living ability and its curative effect is better than Buyang Huanwu decoction group. 5) TCM syndromes score: both Wenyang Fuyuan recipe and Buyang Huanwu decoction can improve the middle of ischemic apoplexy patients. The score of medical symptoms was P0.05 or P0.01A, compared with that after treatment, The treatment group is superior to the control group (P 0.05), suggesting that Wenyang Fuyuan decoction can obviously improve the TCM symptom score of the patients, and its curative effect is better than that of Buyang Huanwu decoction group. Conclusion: this study shows that the therapeutic effect of Wenyang Fuyuan decoction on patients with ischemic stroke in recovery stage is definite and safe. It can improve NIHSS Fugl-Meyer ADL, TCM symptom score.
【学位授予单位】：广西中医药大学
【学位级别】：硕士
【学位授予年份】：2017
【分类号】：R743.3

【参考文献】